Chronic myeloid leukaemia
Top Cited Papers
- 1 July 2007
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 370 (9584), 342-350
- https://doi.org/10.1016/s0140-6736(07)61165-9
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006
- Loss of p53 impedes the antileukemic response to BCR-ABL inhibitionProceedings of the National Academy of Sciences, 2006
- Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre studyEuropean Journal of Haematology, 2005
- Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinibLeukemia, 2005
- Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinibCancer, 2005
- Overriding Imatinib Resistance with a Novel ABL Kinase InhibitorScience, 2004
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Chromosomal localization of human cellular homologues of two viral oncogenesNature, 1982